Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2026

Mar 4, 2026

3535_dva_2026-03-04_98e704af-94e1-4dc2-acde-f32308673972.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA: Share capital increase registered

Aqua Bio Technology ASA: Share capital increase registered

Reference is made to the resolution by the extraordinary general meeting of

Aqua Bio Technology ASA (the "Company") on 16 February 2026, regarding a share

capital increase of NOK 10.0 million. The share capital increase mentioned

above has now been registered with the Norwegian Register of Business

Enterprises. The new share capital of the Company is NOK 26,139,675 divided by

5,227,935 shares, each with a par value of NOK 5.00.

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR Article 17. The information was submitted for publication,

through the agency of the contact persons set out above, at 2026-03-04 11:18

CET.